Journal
NATURE COMMUNICATIONS
Volume 1, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms1101
Keywords
-
Categories
Funding
- Ministry of Education, Culture, Sports, Science, and Technology, Japan [21700399, 21300135, 20650053]
- Nakatomi Foundation
- NIBIO
- Takeda Foundation
- Novartis Foundation for Gerontological Research
- NIH [AG18440, AG022074, AG10435, ES016731]
- Grants-in-Aid for Scientific Research [21300135, 20650053, 21700399, 20500359] Funding Source: KAKEN
Ask authors/readers for more resources
The discovery of alpha-synuclein (alpha S) mutations has made a major contribution to the understanding of the pathogenesis of alpha-synucleinopathies such as Parkinson's disease and dementia with Lewy bodies (DLB). In contrast, less attention has been paid to beta-synuclein (beta S) mutations. In this paper, we show that transgenic (tg) mice expressing DLB-linked P123H beta S develop progressive neurodegeneration, as characterized by axonal swelling, astrogliosis and behavioural abnormalities, with memory disorder being more prominent than motor deficits. Furthermore, cross-breeding of P123H beta S tg mice with alpha S tg mice, but not with alpha S knockout mice, greatly enhanced neurodegeneration phenotypes. These results suggest that P123H beta S is pathogenic and cooperates with pathogenic alpha S to stimulate neurodegeneration in mouse brain, indicating a causative role of P123H beta S in familial DLB. Given the neuritic pathology of beta S in sporadic alpha-synucleinopathies, it appears that alteration of beta S can contribute to the pathogenesis of a broad range of alpha-synucleinopathies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available